System Cross Contamination and Carryover
An internal study was conducted to evaluate the risk of producing a false positive result in either the same run on the
BD Viper System in extracted mode (within run cross-contamination) or in a subsequent run (between run carryover).
Testing was conducted using negative and positive samples on three BD Viper Systems. Negative samples consisted of
CT/GC Q
x
Swab Diluent. Positive samples consisted of a representative analyte (at 10
Swab Diluent. The overall rate of cross-contamination (i.e., with alternating columns of positive and negative samples
and a prevalence of 50%) was 0.41% (9/2208). The overall rate of carryover contamination (i.e., carryover between
successive runs when the prevalence was 50% in the previous run) was 0.36% (8/2208). Cross-contamination and
carryover rates across the three BD Viper Systems are summarized in Table 16.
Table 16: Cross Contamination and Carryover Contamination
Assay
Dispense
Mode
BD Viper
Selected
System
1
2
Dual Assay
3
Overall
1
2
Single Assay
3
Overall
INTERPRETATION OF TABLES
Symbols and Abbreviations
Symbols
(+)
positive
(-)
negative
#
number
%
percentage
Abbreviations
A
Asymptomatic
CI
Confidence Interval
CT
Chlamydia trachomatis
CV
Coefficient of Variation
EC
Extraction Control
FN
False Negative
FNU
Female Neat Urine
FP
False Positive
FS
Female endocervical swab
FUPT
Female urine in Q
FV
Female vaginal swab
GC
Neisseria gonorrhoeae
HIV
Human Immunodeficiency Virus
I
Indeterminate
IFU
Inclusion Forming Units
LE
Liquid level error
LOD
Limit of Detection
MaxRFU
Maximum relative fluorescent units
MNU
Male Neat Urine
MS
Male urethral swab
MUPT
Male urine in Q
n
number
NA
non-applicable
NAAT
Nucleic Acid Amplification Test
NPA
Negative Percent Agreement
NPV
Negative Predictive Value
PA
Percent Agreement
PBS
Phosphate Buffered Saline
PIS
Patient Infected Status
PPA
Positive Percent Agreement
PPV
Positive Predictive Value
QC
Quality Control
S
Symptomatic
SD
Standard Deviation
SDA
Strand Displacement Amplification
STD
Sexually Transmitted Disease
TN
True Negative
TP
True Positive
UPT
Urine Preservative Transport
Cross-Contamination
n
Positive Results Percent Positive
736
5
736
0
736
4
2208
9
190
0
188
1
188
0
566
1
x
UPT
x
UPT
n
0.68
736
0.00
736
0.54
736
0.41
2208
0.00
186
0.53
186
0.00
186
0.18
568
22
5
CT EB/mL) spiked into CT/GC Q
Carryover Contamination
Positive Results
Percent Positive
1
3
4
8
0
1
0
1
x
0.14
0.41
0.54
0.36
0.00
0.54
0.00
0.18